New Delhi . Expectations related to artificial intelligence (AI) are continuously increasing for the treatment of serious diseases like cancer and heart disease. Meanwhile, Anthropic CEO Dario Amodei has made a big claim regarding the medical sector. He says that if AI is used in the right direction and effectively, then cancer, Alzheimer's, heart disease and mental illnesses can become things of the past in less than a decade. His statement raises a new debate about the increasing role of AI in the medical world and possible changes in the future. However, this claim is currently a prediction and cannot be considered as scientific confirmation of the definite eradication of these diseases.
Dario Amadei believes that AI has the potential to increase the speed of medical research manifold. Today, it takes years to understand the causes of a disease, prepare a new medicine and study its effects. AI can rapidly analyze large amounts of scientific data and help researchers identify patterns that are extremely difficult for humans to spot. On the basis of this capability, AI experts hope that in the coming years, the work of drug discovery and biological research can be much faster than before.
Apart from Amadei, many of the world's leading AI experts are also optimistic about the prospects of this technology in the medical field. Elon Musk has also expressed hope to improve health services with the help of AI. He believes that in the future, due to AI, very advanced medical facilities can also be available to the common man. Google AI head Demis Hassabis says that AI can significantly reduce the time taken to search for medicines. He cited the achievements of technology like AlphaFold which has greatly helped scientists in understanding protein structures.
There is certainly enthusiasm in the scientific community about the possibility of accelerating drug research due to AI, but many experts are also exercising caution regarding it. Drug development is not limited to just finding a potential cure for a disease. After preparing any new compound in the laboratory, its safety and effectiveness have to be tested. After this, tests are carried out in several stages and have to undergo a long period of scientific and regulatory scrutiny before getting permission for use in humans.
Jeff Leyden, executive chairman of Vertex Pharmaceuticals, has raised questions about the timeline for finding cures for all major diseases through AI in a very short time. According to him, despite thousands of drug compounds being tested in experiments conducted with AI companies, no drug emerged that could become an effective treatment on its own. This makes it clear that AI is currently not a substitute for medical scientists but a powerful technology to help them.
Despite this, AI can change the direction of medical research. The possibilities for its use are expanding rapidly, from disease identification to drug discovery and personalized treatment planning. If better coordination between AI and medical science develops in the coming years, the time taken to discover cures for many complex diseases can be reduced. But the claim of complete eradication of cancer or other serious diseases is still a future possibility. The real change will be considered when AI based discoveries undergo extensive scientific trials and translate into safe and effective treatments.